What's new

Human medicines European public assessment report (EPAR): Ontozry, cenobamate, Date of authorisation: 26/03/2021, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Ontozry, cenobamate, Date of authorisation: 26/03/2021, Revision: 9, Status: Authorised

Mar 27, 2025 - 11:40
 0
Human medicines European public assessment report (EPAR): Ontozry, cenobamate, Date of authorisation: 26/03/2021, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Ontozry, cenobamate, Date of authorisation: 26/03/2021, Revision: 9, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Rozlytrek, entrectinib...

Next Article

stayAPT Suites Signs Multi-Location Franchise Agreement with Destiny Partners, LLC

Related Posts

Human medicines European public assessment report (EPAR): Ituxredi, rituximab, Date of authorisation: 19/09/2024, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 10, 2025  0

Orphan designation: Serplulimab Treatment of small cell lung cancer, 20/02/2025 Positive

Orphan designation: Serplulimab Treatment of small cell...

Mar 12, 2025  0

Herbal medicinal product: Oleae folium, Olea europaea L., C: ongoing call for scientific data

Herbal medicinal product: Oleae folium, Olea europaea L...

Mar 13, 2025  0